Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Oldakowski currently holds 868 shares of Bionano Genomics, Inc (BNGO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Oldakowski has been a net neutral trader of BNGO stock. They have purchased $0 and sold $0 worth of shares.
Mark Oldakowski's most recent insider trade was on Jun 3, 2026, when they sold 27 shares at $1.30 per share.
Mark Oldakowski serves as Executive at Bionano Genomics, Inc (BNGO). They have executed 12 insider transactions totaling $0 over their tenure at the company.
Mark Oldakowski holds the position of Executive at Bionano Genomics, Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Mark Oldakowski has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Mark Oldakowski was on May 12, 2022, when they sold $58.5K worth of BNGO shares. This transaction involved 41,496 shares at $1.41 per share.
Mark Oldakowski currently owns 868 shares of Bionano Genomics, Inc (BNGO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Oldakowski's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Oldakowski has 12 Form 4 filings on record as an insider at Bionano Genomics, Inc.
Set alerts for Mark Oldakowski and 40,000+ other insiders.